PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32634545-3	2020	MATERIALS AND METHODS: To address these challenges, we sought to conjugate gadolinium-based ultra-small (<5 nm) NPs to an antibody directed against the oncogenic MUC1-C subunit that is overexpressed on the surfaces of many different human cancer types.	Gadolinium	75-85	mucin 1, cell surface associated	Homo sapiens	162-166	
32634545-5	2020	As such, we examined whether systemically administered anti-MUC1-C antibody-conjugated, gadolinium-based NPs (anti-MUC1-C/NPs) could accumulate within cell-line xenograft models of MUC1-C-expressing (H460) lung and (E0771) breast cancers to improve the efficacy of radiation therapy (XRT).	Gadolinium	88-98	mucin 1, cell surface associated	Homo sapiens	115-119